EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity

Yuxin Nong iD, Junquan Lu iD, Danqing Yu iD, Xuebiao Wei iD

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.70107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Yuxin Nong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Pro…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Antioxidants, Human Umbilical Vein Endothelial Cells, Chalcones. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (grant No. Y0120220151), National Natural Science Foundati….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endothelial dysfunction is one of the important mechanisms of organ and tissue damage in sepsis. In this study, we evaluated the effects of neohesperidin dihydrochalone (NHDC) on lipopolysaccharide (LPS)‐induced vascular dysfunction and explored the potential mechanisms.

Methods

In vivo, we assessed vascular leakage in mice by injecting Evans blue dye. In vitro, cell counting kit‐8 (CCK‐8) assay and flow cytometry were used to assess the activity of HUVEC and apoptosis. The effect of LPS on HUVEC barrier was assessed using FITC‐extend membrane assay. The adhesion ability of HUVEC was tested by THP‐1 cell adhesion assay. The antioxidant capacity of cells was measured by detecting the level of mitochondrial membrane potential, ROS, and content of CAT, SOD, GSH, and MDA within the cells. Furthermore, the release of endothelial IL‐1β, IL‐6, and TNF‐α were detected by ELISA, and the expression level of TAK1, ERK1/2, and NFκB were detected by western blot.

Results

Treatment with NHDC effectively alleviated LPS‐induced endothelial permeability and organ damage by reducing reactive oxygen species production and enhancing the antioxidant response. Further investigation suggested that NHDC may exert its protective effects by inhibiting the release of IL‐1β, IL‐6, and TNF‐α, and by decreasing the phosphorylation of key inflammatory signaling molecules, including transforming growth factor‐β‐activated kinase 1 (TAK1), extracellular signal‐regulated kinases 1/2 (ERK1/2), and nuclear factor kappa B (NFκB).

Conclusions

Our study indicate that pretreatment with NHDC may provide protection against LPS‐induced vascular dysfunction by reducing oxidative stress and activation of inflammatory signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesAntioxidantsHuman Umbilical Vein Endothelial CellsChalconesHesperidinEndothelium, VascularReactive Oxygen SpeciesHumansAnimalsMiceMaleApoptosisOxidative StressNF-kappa BMAP Kinase Kinase KinasesSepsisCell AdhesionSignal TransductionCytokinesTHP-1 CellsCapillary PermeabilityMAP Kinase Kinase Kinase 7

Stichwörter der Autor:innen

endothelial dysfunctioninflammationneohesperidin dihydrochalconeoxidative stresssepsis

Substanzen

LipopolysaccharidesAntioxidantsChalconesHesperidinReactive Oxygen SpeciesNF-kappa BMAP Kinase Kinase KinasesCytokinesMAP Kinase Kinase Kinase 7neohesperidin dihydrochalcone

Autor:innen und Institutionen

  • Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guan…
  • Shantou University Medical College, Shantou, China.
  • Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

ORCID-Profile: Yuxin Nong, Junquan Lu, Danqing Yu, Xuebiao Wei

Förderung

  • This study was supported by Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (grant No. Y0120220151), National Natural Science Foundati…

Zitieren

APA

Nong, Y., Lu, J., Yu, D., & Wei, X. (2024). Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70107

Vancouver

Nong Y, Lu J, Yu D, Wei X. Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70107

BibTeX
@article{Nong2024,
  author = {Nong, Yuxin and Lu, Junquan and Yu, Danqing and Wei, Xuebiao},
  title = {Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.70107}
}
Kostenlos starten →